|
|
|
|
|
Detail |
hsa-miR-143 |
|
Unspecified |
MicroRNA expression profiling in prostate cancer. |
2007 |
|
|
|
|
|
|
hsa-miR-143 |
|
Unspecified |
MicroRNA signatures in human ovarian cancer. |
2007 |
|
|
|
|
|
|
hsa-miR-143 |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
hsa-miR-143 |
|
Unspecified |
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. |
2006 |
|
|
|
|
|
|
hsa-miR-143 |
|
Unspecified |
Patterns of known and novel small RNAs in human cervical cancer. |
2007 |
|
|
|
|
|
|
hsa-miR-143 |
|
Unspecified |
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. |
2007 |
|
|
|
|
|
|
hsa-miR-143 |
|
Unspecified |
MicroRNA gene expression deregulation in human breast cancer. |
2005 |
|
|
|
|
|
|
hsa-miR-143 |
|
Unspecified |
MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. |
2007 |
|
|
|
|
|
|
hsa-miR-143 |
|
Unspecified |
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. |
2007 |
|
|
|
|
|
|
hsa-miR-143 |
|
Causal |
Downregulation of microRNAs-143 and -145 in B-cell malignancies. |
2007 |
|
|
|
|
|
|
hsa-miR-143 |
|
Causal |
Downregulation of microRNAs-143 and -145 in B-cell malignancies. |
2007 |
|
|
|
|
|
|
hsa-miR-143 |
|
Causal |
Downregulation of microRNAs-143 and -145 in B-cell malignancies. |
2007 |
|
|
|
|
|
|
hsa-miR-143 |
|
Causal |
MicroRNA-143 and -145 in colon cancer. |
2007 |
|
|
|
|
|
|
hsa-miR-143 |
|
Causal |
MicroRNA-143 regulates adipocyte differentiation. |
2004 |
|
|
|
|
|
|
hsa-miR-143 |
|
Unspecified |
Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. |
2007 |
|
|
|
|
|
|
hsa-miR-143 |
|
Unspecified |
Reduced accumulation of specific microRNAs in colorectal neoplasia. |
2003 |
|
|
|
|
|
|
hsa-miR-143 |
|
Causal |
MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. |
2006 |
|
|
|
|
|
|
hsa-miR-143 |
|
Causal |
MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. |
2009 |
|
|
|
|
|
|
hsa-miR-143 |
|
Unspecified |
MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. |
2009 |
|
|
|
|
|
|
hsa-miR-143 |
|
Causal |
MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells |
2009 |
|
|
|
|
|
|
hsa-miR-143 |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
hsa-miR-143 |
|
Unspecified |
MicroRNA expression profiles in serous ovarian carcinoma. |
2008 |
|
|
|
|
|
|
hsa-miR-143 |
|
Unspecified |
Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling. |
2008 |
|
|
|
|
|
|
hsa-miR-143 |
|
Unspecified |
Up-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet. |
2008 |
|
|
|
|
|
|
hsa-miR-143 |
|
Causal |
Role of miR-143 targeting KRAS in colorectal tumorigenesis. |
2009 |
|
|
|
|
|
|
hsa-miR-143 |
|
Causal |
MicroRNA-143 as a tumor suppressor for bladder cancer. |
2009 |
|
|
|
|
|
|
hsa-miR-143 |
|
Unspecified |
MicroRNA-regulated pathways associated with endometriosis. |
2009 |
|
|
|
|
|
|
hsa-miR-143 |
|
Unspecified |
Over- and under-expressed microRNAs in human colorectal cancer. |
2009 |
|
|
|
|
|
|
hsa-miR-143 |
|
Unspecified |
The expression profile of microRNAs in a model of
7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster. |
2009 |
|
|
|
|
|
|
hsa-miR-143 |
|
Causal |
Decreased Expression of MicroRNA-143 and -145 in Human Gastric Cancers. |
2009 |
|
|
|
|
|
|
hsa-miR-143 |
|
Causal |
Role of microRNA-143 in Fas-mediated apoptosis in human T-cell leukemia Jurkat cells. |
2009 |
|
|
|
|
|
|
hsa-miR-143 |
|
Causal |
Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. |
2009 |
|
|
|
|
|
|
hsa-miR-143 |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
hsa-miR-143 |
|
Unspecified |
Alteration of microRNA expression in vinyl-carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol |
2009 |
|
|
|
|
|
|